SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-235222
Filing Date
2022-08-31
Accepted
2022-08-31 16:28:05
Documents
16
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d399738d8k.htm   iXBRL 8-K 44098
2 EX-10.1 d399738dex101.htm EX-10.1 188258
3 EX-99.1 d399738dex991.htm EX-99.1 12627
8 GRAPHIC g399738g0831091545442.jpg GRAPHIC 2640
  Complete submission text file 0001193125-22-235222.txt   472238

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmra-20220831.xsd EX-101.SCH 3935
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20220831_def.xml EX-101.DEF 14512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20220831_lab.xml EX-101.LAB 24095
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20220831_pre.xml EX-101.PRE 15604
10 EXTRACTED XBRL INSTANCE DOCUMENT d399738d8k_htm.xml XML 5401
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 221218250
SIC: 2834 Pharmaceutical Preparations